Roflumilast for asthma: Weighing the evidence Journal Articles

authors

• Bateman, ED
• O'Byrne, Paul
• Buhl, R
• Rabe, KF

status

• published 

publication date

• December 2015

has subject area

• 1103 Clinical Sciences (FoR)
• 1115 Pharmacology and Pharmaceutical Sciences (FoR)
• Administration, Inhalation (MeSH)
• Adrenal Cortex Hormones (MeSH)
• Aminopyridines (MeSH)
• Asthma (MeSH)
• Benzamides (MeSH)
• Cyclopropanes (MeSH)
• Humans (MeSH)
• Phosphodiesterase 4 Inhibitors (MeSH)
• Respiratory System (Science Metrix)

published in

• Pulmonary Pharmacology and Therapeutics  Journal

keywords

• Administration, Inhalation
• Adrenal Cortex Hormones
• Aminopyridines
• Asthma
• Benzamides
• Cyclopropanes
• FEV(1)
• Humans
• ICS
• Phosphodiesterase 4 Inhibitors
• Placebo
• Roflumilast
• Safety

Digital Object Identifier (DOI)

• 10.1016/j.pupt.2015.08.001

PubMed ID

• 26278190

start page

• S1

end page

• S3

volume

• 35